Fengcai Wei

997 citations
52 papers · 784 indexed · h-index 16

Impact in

Papers in

Fengcai Wei

50 papers receiving 778 citations

Peers

Fengcai Wei
Comparison fields: 5 of 92
  • Cancer Research 176
  • Otorhinolaryngology 37
  • Oncology 217
  • Immunology 148
  • Periodontics 30
Replace Eri Sasabe with:
Eri Sasabe Japan
Hitoshi Miyashita Japan
Christina Springstead Scanlon United States
Naoya Arai Japan
Yunong Wu China
Yuh‐Ling Chen Taiwan
Yong Hoon South Korea
Masashi Shin Japan
Katarzyna A. Podyma‐Inoue Japan
Zhihang Zhou China
Fengcai Wei relative to Eri Sasabe Japan Eri Sasabe's profile →
Citations per field
00.5×1.5×1.8×
Eri Sasabe · 1×
Citations per year

Countries citing papers authored by Fengcai Wei

Since Specialization
Citations

This map shows the geographic impact of Fengcai Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengcai Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengcai Wei more than expected).

Fields of papers citing papers by Fengcai Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengcai Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengcai Wei. The network helps show where Fengcai Wei may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fengcai Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fengcai Wei Line = papers co-authored together Fengcai Wei links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20191
3 201718
4 20173
5 201620
6 20144
7 201332
8 201210
9 201243
10 201110
11 201116
12 20115
13 201154
14 201017
15 201022
16 200939
17 200911
18 200723
19
The Thickness for BCP Affects about OLED Device
20052
20 19951

About Fengcai Wei

Fengcai Wei is a scholar working on Immunology and Allergy, Anatomy, Periodontics, Cancer Research and Developmental Neuroscience, having authored 52 papers that have together received 784 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (6 papers), Mesenchymal stem cell research (5 papers), Immune cells in cancer (4 papers), Salivary Gland Tumors Diagnosis and Treatment (4 papers), Oral Health Pathology and Treatment (3 papers), Oral and Maxillofacial Pathology (3 papers), Peptidase Inhibition and Analysis (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Cancer Research (176 citations), Otorhinolaryngology (37 citations), Oncology (217 citations), Immunology (148 citations) and Periodontics (30 citations). Fengcai Wei has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xun Qu, Shaohua Liu, Xiaoying Zhang, Yingwei Hu, Guixiang Liu, Chengjun Zhou, Shaohua Liu, Qianqian Shao, Xiaoyi Xu and Zheng-Gang Chen. Their work appears in journals such as Oral Oncology, Acta Pharmacologica Sinica, Acta Biochimica et Biophysica Sinica, Journal of Oral and Maxillofacial Surgery and Inflammation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026